Stock info Baywa | Filter  Basic-Info

Baywa

Baywa's main office is based in Munich. Baywa mainly operates in the health care eq. & services sector. Klaus Josef Lutzâ� is operating by ' CEO. The global health care companies gained around 102 percent worldwide over the last 10 years. Measured since 2011 the sector is 64 percent higher and over the past 12 months (December 2015-2016) there is a plus of 102 percent.

Past year was a negative year for Baywa investors

Over the past year the company' stock gained around 12 percent. The period between August 2011 and August 2016 was a profitable period for the investors. The stock rose on average 11 percent. Baywa's revenues between 2011 and 2015 were very volatile and moved between 10,53 billion euros and 14,93 billion euros. Baywa's net results between 2011 and 2015 were relatively stable and moved between 69,8 million euros and 61,6 million euros.

Over the past 5 years the German company paid out dividends. On average Baywa's dividend yield over the past 5 years was around 3,65 percent annually.

Healthy financed: not so much debt Baywa

Last year the balance sheet of the German company was worth 6,04 billion euros. 5,23 billion euros (86,59 percent of the total balance sheet) was financed by debt. Last year the health care company's price/earnings-ratio (PE) was around 18. So the investors valued the stock at 18 times 2015' earnings per share. Many analysts say that based on her price/earnings-ratio and dividend yield the German stock can be seen as a value stock.

At the end of 2015 the health care company's market size (her number of outstanding share times the stock price) equaled around 990,11 million euros. At the end of 2015 the German company had around 34,64 million stocks listed.

All the annual reports of Baywa are available here. More information about Baywa can be found it's website. .